论文部分内容阅读
About 75%of all bladder cancer diagnosed are nonmuscle invasive bladder cancer(NMIBC),recurring over 50%of them after transurethral resection of the bladder tumor.In order to prevent recurrences,adjuvant intravesical chemotherapy with mitomycin C and immu